Is Weight-Loss Surgery in China Safe? A Top Bariatric Surgeon Answers 9 Key Questions

On Google and international medical-tourism platforms, "gastric sleeve in China" and "gastric bypass cost China" have become steadily rising search terms. The reason is straightforward: the same laparoscopic operation in China commonly costs a fraction—often one third to one half—of the price in the United States or the United Kingdom, with shorter waiting times and surgeons who often perform a very high volume of procedures.

At the same time, weight-loss surgery is among the most widely misunderstood of operations. Is it simply "stomach-stapling to lose weight"? How high must one's BMI be? How should a patient choose between a sleeve and a bypass? Can the weight return after a few years? Is the surgery safe?

To answer these questions properly, one name is unavoidable in Chinese bariatric surgery: Professor Wang Cunchun. Since performing the first minimally invasive bariatric operation in South China in 2000, his team at the First Affiliated Hospital of Jinan University has, according to 2025 public reports, completed more than 5,000 bariatric and metabolic procedures. Drawing on his team's public views and the 2024 national guideline, this article addresses the questions international patients ask most.

1. What exactly is weight-loss surgery? Is it the same as "cutting the stomach to slim down"?

Bariatric and metabolic surgery uses minimally invasive laparoscopic techniques to reduce the volume of the stomach and/or alter the digestive pathway, thereby limiting food intake, reducing nutrient absorption, and changing gastrointestinal hormones. It is a recognized treatment for metabolic disease; it is neither liposuction nor a cosmetic procedure.

Two operations dominate current practice worldwide:

1. Laparoscopic sleeve gastrectomy (SG): About 70%–80% of the stomach is removed, leaving a narrow, banana-shaped tube of roughly 100–150 millilitres. Removing the fundus, which produces the hunger hormone ghrelin, also markedly reduces appetite. Because the intestinal anatomy is left unchanged, the procedure is comparatively simple and carries fewer complications. It is now the most common operation worldwide and is overwhelmingly dominant in China: national COMES registry data attribute about 87.8% of recorded operations to the sleeve in 2022 and 81.5% in 2023.

2. Roux-en-Y gastric bypass (RYGB): A small gastric pouch of about 30 millilitres is created at the top of the stomach and connected to the mid-to-distal small intestine, so that food bypasses most of the stomach and the duodenum. It restricts both intake and absorption and produces particularly strong improvement in blood glucose. It is regarded as the "gold standard" for patients with moderate-to-severe type 2 diabetes, severe gastroesophageal reflux, or extreme obesity.

Professor Wang notes that more than ten operative designs appeared during the history of bariatric surgery; after decades of selection, only a few mature procedures, principally the sleeve and the bypass, remain and are recognized by surgeons worldwide.

2. Who qualifies for surgery? How high must the BMI be?

This is the first and strictest threshold. The criteria in the current Chinese national guideline align closely with mainstream international (IFSO/ASMBS) standards; surgery is not available simply because a patient wishes to be thinner. Under the 2024 guideline, surgery applies principally to adults aged 18–70:

• BMI ≥ 32.5: surgery is strongly recommended;

• BMI ≥ 27.5 with type 2 diabetes: surgery is indicated under the 2024 guideline, regardless of whether medical treatment has fully succeeded;

• 27.5 ≤ BMI < 32.5 with another obesity-related condition such as hypertension, dyslipidaemia, fatty liver, or obstructive sleep apnoea that has not responded to medical treatment: surgery may be considered;

• 25 ≤ BMI < 27.5 with type 2 diabetes and poorly controlled blood glucose despite intensive medical treatment: surgery may be undertaken only as an ethics-approved research protocol, after strict multidisciplinary assessment and informed consent;

• BMI < 25: surgery is not currently recommended.

Selected adults over 70 and carefully selected adolescents may be assessed individually by a multidisciplinary team; age is not the sole criterion and is weighed alongside overall health.

Under the Chinese Guidelines for the Diagnosis and Treatment of Obesity (2024 edition), a BMI of 28.0–32.4 defines mild obesity, 32.5–37.4 moderate obesity, 37.5–49.9 severe obesity, and 50 or above very severe (extreme) obesity. Central obesity—defined by a waist circumference of at least 90 centimetres in men or 85 centimetres in women—may also justify a stronger recommendation.

Professor Wang emphasizes the East Asian pattern: "At the same BMI of 25, Chinese patients develop metabolic abnormalities more readily than Western patients." Because East Asians tend genetically to accumulate fat around the internal organs, Chinese guidelines are more proactive about surgery when complications are present, rather than relying only on Western BMI cut-off points.

3. How long has bariatric surgery existed in China, and are the surgeons experienced enough?

China started later than Western countries but has developed rapidly, a point international patients often underestimate.

• Professor Wang's team performed the first minimally invasive bariatric operation in South China in 2000 and China's first laparoscopic gastric bypass in 2004. He was also the first Chinese surgeon to perform a single-incision laparoscopic gastric bypass and to propose internationally the concept of "precision laparoscopic bariatric surgery."

• Nationwide, the recorded Chinese caseload was about 23,040 operations in 2021, reached 27,001 in the national COMES registry for 2022 (with an estimated true national total of about 30,071), and rose to an estimated 37,249 in 2023, making China one of the largest and fastest-growing bariatric-surgery markets in Asia. (The round figure of "close to 40,000 in 2023," used in some media reports, is the rounded version of the same official estimate.)

• At the Bariatric Center of the First Affiliated Hospital of Jinan University alone, roughly 600–800 procedures are now performed each year, with an average patient age of about 32. According to 2025 public reports, Professor Wang's team had completed more than 5,000 bariatric and metabolic operations since 2000.

This large and rapidly growing caseload means that front-line Chinese bariatric surgeons accumulate intensive hands-on experience in complex situations such as super-obesity, multiple metabolic comorbidities, and revisional surgery.

4. How much weight can the surgery remove, and does it really work for type 2 diabetes?

The outcomes are supported by clear evidence and are measured by the percentage of excess weight lost, rather than by the number on the scale alone.

• Sleeve gastrectomy typically produces 50%–60% excess weight loss;

• Gastric bypass typically produces 60%–70% excess weight loss, and remission of type 2 diabetes can exceed 80% .

In his public interview on World Obesity Day 2025, Professor Wang reported that patients with severe obesity lose an average of 30%–40% of their total body weight in the first year, and that among patients who follow behavioural intervention and standardized management, the ten-year weight-maintenance rate exceeds 70%.

"Diabetes remission" means that blood glucose remains at target over the long term without glucose-lowering medication; it does not apply to everyone. Professor Wang's team has noted from its early practice that the best blood-glucose outcomes are generally seen in patients who still retain some pancreatic islet function and whose diabetes duration is not excessively long. The beneficial effect of surgery on type 2 diabetes and metabolic syndrome has been written into diabetes guidelines in multiple countries.

5. Can the weight return afterwards? Is surgery a permanent solution?

This is the most realistic concern for international patients, and the Chinese experts are candid: surgery is neither magic nor a once-and-for-all fix.

• Five-to-ten-year follow-up observations from the Department of Gastrointestinal Surgery at the First Affiliated Hospital of Jinan University indicate that roughly 5%–20% of patients regain some weight after surgery;

• The team's long-term data contrast the two outcomes starkly: among patients who follow behavioural intervention, the ten-year maintenance rate is above 70%; among those who return to an unrestricted diet, about half regain weight within five years.

Weight regain is driven mainly by unchanged behaviour, such as returning to snacks, sugary drinks, or binge eating. Chief Physician Yang Jingge points out that in the "three-tier ladder" of weight management, sound diet and exercise always form the base, while surgery addresses only the physiological restriction of intake. The operation itself accounts for roughly 40%–50% of long-term weight management; the other 50%–60% depends on postoperative lifestyle. A properly run bariatric center therefore requires lifelong follow-up, at 1, 3, 6, 12, and 24 months and annually thereafter.

6. Is bariatric surgery safe? How high is the risk of complications?

When performed by an experienced team in a mature center using laparoscopy, the safety profile is already high.

• Public patient-education material from leading Chinese bariatric centers states that, in experienced hands, the probability of surgery-related complications is below 0.5% (five per thousand) ; the principal early complications are leakage, bleeding, and obstruction, all of which are uncommon and have established treatments. National COMES data record a perioperative mortality rate of around 0.01%–0.02% .

• The procedures are minimally invasive and associated with small wounds and rapid recovery. With the enhanced-recovery ("precision surgery, no routine gastric tube or drain") approach promoted by Professor Wang's team, patients are commonly discharged 2–5 days after the main operations.

Safety presupposes strict selection and multidisciplinary assessment. The guidelines explicitly list contraindications, including non-obese type 1 diabetes, essentially lost islet function, uncontrolled drug or alcohol addiction, uncontrolled psychiatric illness, inability or very poor willingness to comply with lifelong postoperative management, and any general condition that makes anaesthesia or surgery intolerable.

7. Why must vitamins be taken for life, and how does daily life change?

This is the point Chinese experts stress repeatedly and that some overseas intermediaries tend to omit: lifelong nutritional management is required after bariatric surgery.

• The diet progresses through liquids, semi-liquids, soft foods, and then a normal diet. Patients must chew thoroughly, eat frequent small meals, ensure adequate protein, and avoid high-sugar and high-fat foods and binge eating over the long term.

• Because intake and absorption fall, patients are prone to vitamin and mineral deficiencies (vitamin D deficiency is especially common after a sleeve, and the risk is higher after a bypass). They must take a lifelong multivitamin together with calcium, iron, and vitamin D, and undergo regular blood tests to prevent anaemia and osteoporosis.

In Professor Wang's words, "Surgery is not magic, but patients need lifelong vitamin supplementation, and postoperative management determines the final result." For patients willing to accept long-term follow-up and lifestyle adjustment, surgery is "a new starting point for a healthy life"; those who expect to "stay thin while lying down, with no self-discipline" are not suitable candidates.

8. Weight-loss drugs such as GLP-1 agonists are popular now; is surgery still necessary?

This has become the most frequent new question since 2025. Professor Wang's view is that obesity should be treated through an individualized, stepped approach of lifestyle, medication, and surgery, and that drugs and surgery are not opposed to each other.

• Lifestyle intervention is the foundation of all treatment, but patients with moderate-to-severe obesity rarely maintain weight loss through diet and exercise alone.

• Newer injectable drugs produce substantial but dose-dependent weight loss. In the STEP 1 trial, semaglutide 2.4 mg produced mean weight loss of about 14.9% at 68 weeks; in SURMOUNT-1, the dual GIP/GLP-1 agonist tirzepatide 15 mg produced about 20.9% at 72 weeks (up to 22.5% in the trial's efficacy analysis). They also improve blood pressure and lipids, but they generally require long-term use, and weight commonly rebounds after discontinuation.

• For patients with a BMI of 32.5 or above, or with severe metabolic complications, surgery retains irreplaceable value in the magnitude and durability of weight loss and in diabetes remission. In clinical practice, severely obese patients may even use a GLP-1 drug for a short period before surgery to shrink the liver and reduce operative risk, and patients who regain weight after surgery may be helped by medication or revisional surgery.

9. What does bariatric surgery cost in China, and how should an international patient choose a center?

Cost (public market ranges for 2026; for reference only, and subject to the hospital's written quotation):

• At a Grade-A tertiary public hospital or international hospital in a major Chinese city, the all-inclusive cost of a laparoscopic sleeve gastrectomy (preoperative testing, surgery, and hospitalization) is publicly quoted at roughly RMB 40,000–80,000 (about USD 5,500–11,000) ; international or foreign-invested private hospitals generally charge about RMB 60,000–100,000. A gastric bypass is usually somewhat more expensive than a sleeve.

• For comparison, a sleeve or bypass in the United States commonly costs USD 15,000–35,000, and private treatment in the United Kingdom is commonly quoted at roughly GBP 10,000–20,000. Even after international flights, accommodation, and a recommended stay in China of about 10–14 days for surgery and initial postoperative monitoring, the overall cost usually retains a clear advantage.

When choosing an institution and surgeon, use the following criteria:

1. Prefer a Grade-A tertiary hospital or a reputable international hospital with a dedicated bariatric/metabolic center, and confirm that it provides a multidisciplinary team covering endocrinology, nutrition, anaesthesia, and psychological assessment, rather than an institution that promises only a "cheap, fast operation."

2. Verify the operating surgeon's credentials and cumulative procedural volume: registration as a surgeon, long-standing specialist experience in bariatric surgery, and the team's annual volume, complication rates, and follow-up data.

3. Confirm a transparent procedure and price: the operative approach, whether imported stapling devices are used, which items are included, and how complications would be managed should all be stated in writing before surgery.

4. Value the capacity for long-term postoperative follow-up. As a patient who must return home, confirm that the hospital can provide English records, staged remote follow-up guidance, and a plan for connecting nutritional monitoring and vitamin supplementation after departure.

5. Be wary of over-promising. Any institution marketing "guaranteed thinness," "no rebound," or "no need to diet or exercise" should be ruled out, because such claims contradict established medical consensus.

Conclusion

China's strong value in bariatric surgery rests on three things occurring at once: the surgical experience built as the annual national caseload grew from about 23,000 in 2021 to an estimated 37,000 in 2023, BMI eligibility criteria and operative standards aligned with international IFSO/ASMBS guidance, and prices at a fraction of Western levels.

Yet every public statement from Professor Wang's team points to the same sober conclusion: surgery provides a "restart," not an effortless victory. For international patients who meet the medical criteria and are willing to accept lifelong follow-up and lifestyle management, a mature Chinese bariatric center can offer an operation of international standard at a far lower cost. What patients must do correctly is choose the right institution, pass a proper assessment, and sustain postoperative management.